Harmful combo drugs flood market

Irrational drug combos flood market; regulator does little to remove them
Harmful combo drugs flood market
Published on

The Planning Commission of India has set up a working group to look into the drug regulatory mechanism in the country. One of the tasks the panel has been entrusted is to devise a strategy to weed out irrational drugs from the market.

Most of these drugs are fixed dose combination drugs (FDCs), freely prescribed by doctors and often sold over the counter, endangering public health. The working group is likely to submit its report by August 31. An FDC combines two or more active ingredients in a pre-determined ratio, and an irrational FDC is one which has no proven efficacy over single compound drugs administered separately and can be harmful.

FDCs are among the most sold drugs in the country. On a regular day, the Apollo pharmacy in Kalkaji area of south Delhi sells three to four strips of Norflox TZ. The drug is commonly prescribed for diarrhoea. Norflox TZ, manufactured by Cipla Ltd, a Mumbai-based pharmaceutical company, is a combination of two antibiotics— norfloxacin, used in bacterial infections, and tinidazole, used in amoebic dysentery. The combination is called irrational because if a person is suffering from amoebic dysentery and is prescribed the drug, he or she would end up consuming norfloxacin unnecessarily. A 2007 study by A Chakrabarti, professor at the department of pharmacology at the Sikkim Manipal Institute of Medical Sciences, found 59 per cent prescriptions for diarrhoea were FDCs. These FDCs are harmful. For instance, a patient taking Norflox may develop resistance to norfloxacin and not respond to it when he or she needs to be treated with it, says Urmila Thatte, head of the department of clinical pharmacology at KEM Hospital in Mumbai. Cipla refused to comment. Such drugs pose a risk to the whole community because drug resistant germs are transmitted from one person to another.

Whether the Planning Commission panel can check the sale of FDCs is something that remains to be seen. “We are trying to develop an effective mechanism to remove unnecessary drug combinations from the market because earlier attempts of the government have failed,” says Gopal Dabade, member of the Planning Commission panel. He works with the Drug Action Forum, a non-profit based in Karnataka.

A BAD DOSE
   
1. COMBINATION
Ferric ammonium citrate, B12, folic acid and alcohol

PRESCRIBED FOR
Anaemia

WHY HARMFUL
Ferric salt is poorly absorbed by the body. Alcohol not needed for treating anaemia
 
2. COMBINATION
Nimuselide+paracetamol

PRESCRIBED FOR
Pain and fever

WHY HARMFUL
There is a worldwide ban on prescribing nimesulide for children because of risk to liver. It combines two similar drugs—both are analgesic and antipyretic
 
3. COMBINATION
B1, B6, B12, nicotinamide, calcium pantothenate

PRESCRIBED FOR
Multivitamin deficiency

WHY HARMFUL
B1, B6, B12 combination is banned because deficiency of the three vitamins rarely occurs together. To avoid ban, Merck has combined them with other compounds
 
4. COMBINATION
Norfloxacin+tinidazole

PRESCRIBED FOR
Diarrhoea

WHY HARMFUL
Norfloxacin treats bacterial diarrhoea and tinidazole treats amoebic dysentery. Combination is unnecessary as both the complications rarely occur together. May lead to antibiotic resistance
 
AVOID THESE COMBINATIONS
  • Atenolol for heart disease combined with anti-anxiety drug alprazolam. It is prescribed for hypertension, presuming all patients of hypertension suffer from anxiety. Alprazolam is addictive.
  • Diclofenace, an anti-inflammatory drug, plus famotidine for gastric ulcer and gastrooesophagal diseases. The number of times the two drugs are to be taken differs
  • Ranitidine prescribed for stomach ulcers combined with dicyclomine for irritable bowel syndrome. Both conditions rarely occur together
294 drugs under scanner
Why they are prescribed
Profit motive
Who is to blame?

Related Stories

No stories found.
Down To Earth
www.downtoearth.org.in